Vivo Bio Tech Ltd

📊 Vivo Bio Tech Q1 2026: Revenue Up 14%, But Profits Fall Sharply

- Consolidated revenue rose to Rs. 1,427.97 lacs in Q1 2026 from Rs. 1,251.16 lacs in Q1 2025, up ~14.1%.

- Standalone revenue increased to Rs. 1,413.94 lacs from Rs. 1,241.86 lacs, up ~13.9%.

- Consolidated net profit after tax declined sharply to Rs. 18.76 lacs from Rs. 133.71 lacs.

- Standalone net profit after tax decreased to Rs. 18.43 lacs from Rs. 137.32 lacs.

- Consolidated EPS fell to Rs. 0.08 from Rs. 0.74, and standalone EPS dropped to Rs. 0.08 from Rs. 0.76.